Association Between Variants of PRDM1 and NDP52 and Crohns Disease, Based on Exome Sequencing and Functional Studies

David Ellinghaus, Hu Zhang, Sebastian Zeissig, Simone Lipinski, Andreas Till, Tao Jiang, Bjorn Stade, Yana Bromberg, Eva Ellinghaus, Andreas Keller, Manuel A Rivas, Jurgita Skieceviciene, Nadezhda T Doncheva, Xiao Liu, Qing Liu, Fuman Jiang, Michael Forster, Gabriele Mayr, Mario Albrecht, Robert HaslerBernhard O Boehm, Jane Goodall, Carlo R Berzuini, James Lee, Vibeke Andersen, Ulla Vogel, Limas Kupcinskas, Manfred Kayser, Michael Krawczak, Susanna Nikolaus, Rinse K Weersma, Cyriel Y Ponsioen, Miquel Sans, Cisca Wijmenga, David P Strachan, Wendy L McArdle, Sverine Vermeire, Paul Rutgeerts, Jeremy D Sanderson, Christopher G Mathew, Morten H Vatn, Jun Wang, Markus M Nothen, Richard H Duerr, Carsten Buning, Stephan Brand, Jurgen Glas, Juliane Winkelmann, Thomas Illig, Anna Latiano, Vito Annese, Jonas Halfvarson, Mauro Damato, Mark J Daly, Michael Nothnagel, Tom H Karlsen, Suresh Subramani, Philip Rosenstiel, Stefan Schreiber, Miles Parkes, Andre Franke

Research output: Contribution to journalArticle (Academic Journal)peer-review

122 Citations (Scopus)


BACKGROUND& AIMS: Genome-wide association studies (GWASs) have identified 140 Crohn's disease (CD) susceptibility loci. For most loci, the variants that cause disease are not known and the genes affected by these variants have not been identified. We aimed to identify variants that cause CD through detailed sequencing, genetic association, expression, and functional studies. METHODS: We sequenced whole exomes of 42 unrelated subjects with Crohn's disease (CD) and 5 healthy individuals (controls), and then filtered single-nucleotide variants by incorporating association results from meta-analyses of CD GWASs and in silico mutation effect prediction algorithms. We then genotyped 9348 patients with CD, 2868 with ulcerative colitis, and 14,567 controls, and associated variants analyzed in functional studies using materials from patients and controls and in vitro model systems. RESULTS: We identified rare missense mutations in PR domain-containing1 (PRDM1) and associated these with CD. These increased proliferation of T cells and secretion of cytokines upon activation, and increased expression of the adhesion molecule L-selectin. A common CD risk allele, identified in GWASs, correlated with reduced expression of PRDM1 in ileal biopsies and peripheral blood mononuclear cells (combined P=1.6×0(-8)). We identified an association between CD and a common missense variant, Val248Ala, in nuclear domain 10 protein 52 (NDP52) (P=4.83×10(-9)). We found that this variant impairs the regulatory functions of NDP52 to inhibit NFκB activation of genes that regulate inflammation and affect stability of proteins in toll-like receptor pathways. CONCLUSIONS: We have extended GWAS results and provide evidence that variants in PRDM1 and NDP52 determine susceptibility to CD. PRDM1 maps adjacent to a CD interval identified in GWASs and encodes a transcription factor expressed by T and B cells. NDP52 is an adaptor protein that functions in selective autophagy of intracellular bacteria and signaling molecules, supporting the role for autophagy in pathogenesis of CD.
Original languageEnglish
Publication statusPublished - 25 Apr 2013

Bibliographical note

Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.


Dive into the research topics of 'Association Between Variants of PRDM1 and NDP52 and Crohns Disease, Based on Exome Sequencing and Functional Studies'. Together they form a unique fingerprint.

Cite this